Rani Therapeutics Holdings, Inc. (RANI) Total liabilities 2020–2025
Rani Therapeutics Holdings, Inc. (RANI) total liabilities at each fiscal year-end, per SEC filings.
$17.1MFY2025 · since FY2020: $8.0M → $17.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.1M | -48.4% |
| FY2024 | $33.1M | +2.1% |
| FY2023 | $32.5M | -4.6% |
| FY2022 | $34.0M | +1188.8% |
| FY2021 | $2.6M | -67.2% |
| FY2020 | $8.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice